Related Experiment Video
Updated: Jul 7, 2026

3D Microtissues for Injectable Regenerative Therapy and High-throughput Drug Screening
Published on: October 4, 2017
Current status of regenerative medical therapy based on drug delivery technology
1Department of Biomaterials, Field of Tissue Engineering, Institute for Frontier Medical Sciences, Kyoto University, 53 Kawara-cho Shogoin, Sakyo-ku, Kyoto 606-8507, Japan. yasuhiko@frontier.kyoto-u.ac.jp
Abstract:
Regenerative medical therapy has been expected to compensate for the therapeutic disadvantages of reconstructive surgery and organ transplantation, as well as create a new therapeutic strategy. The objective of regenerative medical therapy is to induce the regeneration and repair of defective tissues based on the natural healing potential of patients themselves. For successful tissue regeneration, it is indispensable to provide cells with a local environment which enables them to proliferate and differentiate efficiently, resulting in cell-induced tissue regeneration. Tissue engineering is a biomedical technology or methodology to create this regeneration environment by making use of biomaterials. Several concrete examples of regenerative medical therapy based on the cell scaffolding and drug delivery system of growth factors and genes are introduced here to emphasize the significance of biomaterials in tissue engineering.
Related Concept Videos
Modified-Release Drug Delivery Systems: Overview
Drug Delivery: Overview
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the gastrointestinal...
Modified-Release Drug Delivery Systems: Classification
Modified-Release Drug Delivery Systems: Rate-Programmed II
Modified-Release Drug Delivery Systems: Rate-Programmed I
Modified-Release Drug Delivery Systems: Site-Targeted

